Biologics: Quality Developments & Manufacturing Summit
14-15

May 2020

Affiliated With The 4th Annual Antibody Drug Conjugates Summit

We are pleased to invite you to the Biologics: Quality Developments & Manufacturing Summit, scheduled for May 14-15, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development and manufacturing of biologics, including novel modalities. It is an honour and privilege to invite you to parti...

We are pleased to invite you to the Biologics: Quality Developments & Manufacturing Summit, scheduled for May 14-15, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development and manufacturing of biologics, including novel modalities. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in May!

more info
Who Should Attend

Chief Executives, Vice Presidents, Directors, Heads, Leaders and Managers specialising in:

  • ADC
  • CMC
  • Engineering
  • GMP
  • Manufacturing
  • Plant/Site Management
  • Process engineers
  • Production
  • Supply Chain
  • Quality
  • Biologics
  • Contract Manufacturing
  • Facility Management
  • Investment
  • Novel Modalities
  • Process science
  • Procurement
  • Regulatory
  • QA/QC
Key Practical Learning Points of the Summit

Optimised biologics process development, manufacturing, cost and quality efficiency
Emerging science and technologies to facilitate development and manufacturing of high-quality and new modalities biologic drugs
Recent developments in relation to culture, QbD, ICH Guidelines, evolving quality of biologics production
Critical regulatory CMC strategies to empower successful biologics submissions
Innovative technical and operations approaches for biologics production in state-of-the-art facilities

"